Home > > > > > Report Detail

Global Tuberculosis Diagnostic Market Insights, Forecast to 2029

Publisher Name :
Date: 14-Jun-2023
No. of pages: 107
Inquire Before Buying

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Market Analysis and Insights: Global Tuberculosis Diagnostic Market

The global Tuberculosis Diagnostic market is projected to grow from US$ 2737.2 million in 2023 to US$ 3373.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.

APAC is the largest market, with a share over 54%, followed by Americas and Europe, b

Report Includes

This report presents an overview of global market for Tuberculosis Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Tuberculosis Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tuberculosis Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis Diagnostic revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Tuberculosis Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Tuberculosis Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid and Hain Lifescience, etc.

By Company

- Thermo Fisher Scientific

- Hologic Corporation

- Abbott

- Becton Dickinson

- Roche

- bioMerieux

- Sanofi

- Cepheid

- Hain Lifescience

- QIAGEN

Segment by Type

- Radiographic Method

- Diagnostic Laboratory Methods

- Nucleic Acid Testing

- Phage Assay

- Detection of Latent Infection

- Cytokine Detection Assay

- Detection of Drug Resistance

Segment by Application

- Infants

- Adults

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Tuberculosis Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Diagnostic companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis Diagnostic revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Tuberculosis Diagnostic Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Radiographic Method
1.2.3 Diagnostic Laboratory Methods
1.2.4 Nucleic Acid Testing
1.2.5 Phage Assay
1.2.6 Detection of Latent Infection
1.2.7 Cytokine Detection Assay
1.2.8 Detection of Drug Resistance
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Infants
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnostic Market Perspective (2018-2029)
2.2 Global Tuberculosis Diagnostic Growth Trends by Region
2.2.1 Tuberculosis Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tuberculosis Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 Tuberculosis Diagnostic Market Dynamics
2.3.1 Tuberculosis Diagnostic Industry Trends
2.3.2 Tuberculosis Diagnostic Market Drivers
2.3.3 Tuberculosis Diagnostic Market Challenges
2.3.4 Tuberculosis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tuberculosis Diagnostic by Players
3.1.1 Global Tuberculosis Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tuberculosis Diagnostic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Tuberculosis Diagnostic Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2022
3.5 Global Key Players of Tuberculosis Diagnostic Head office and Area Served
3.6 Global Key Players of Tuberculosis Diagnostic, Product and Application
3.7 Global Key Players of Tuberculosis Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Diagnostic Breakdown Data by Type
4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2024-2029)
5 Tuberculosis Diagnostic Breakdown Data by Application
5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tuberculosis Diagnostic Market Size (2018-2029)
6.2 North America Tuberculosis Diagnostic Market Size by Type
6.2.1 North America Tuberculosis Diagnostic Market Size by Type (2018-2023)
6.2.2 North America Tuberculosis Diagnostic Market Size by Type (2024-2029)
6.2.3 North America Tuberculosis Diagnostic Market Share by Type (2018-2029)
6.3 North America Tuberculosis Diagnostic Market Size by Application
6.3.1 North America Tuberculosis Diagnostic Market Size by Application (2018-2023)
6.3.2 North America Tuberculosis Diagnostic Market Size by Application (2024-2029)
6.3.3 North America Tuberculosis Diagnostic Market Share by Application (2018-2029)
6.4 North America Tuberculosis Diagnostic Market Size by Country
6.4.1 North America Tuberculosis Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Tuberculosis Diagnostic Market Size by Country (2018-2023)
6.4.3 North America Tuberculosis Diagnostic Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostic Market Size (2018-2029)
7.2 Europe Tuberculosis Diagnostic Market Size by Type
7.2.1 Europe Tuberculosis Diagnostic Market Size by Type (2018-2023)
7.2.2 Europe Tuberculosis Diagnostic Market Size by Type (2024-2029)
7.2.3 Europe Tuberculosis Diagnostic Market Share by Type (2018-2029)
7.3 Europe Tuberculosis Diagnostic Market Size by Application
7.3.1 Europe Tuberculosis Diagnostic Market Size by Application (2018-2023)
7.3.2 Europe Tuberculosis Diagnostic Market Size by Application (2024-2029)
7.3.3 Europe Tuberculosis Diagnostic Market Share by Application (2018-2029)
7.4 Europe Tuberculosis Diagnostic Market Size by Country
7.4.1 Europe Tuberculosis Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Tuberculosis Diagnostic Market Size by Country (2018-2023)
7.4.3 Europe Tuberculosis Diagnostic Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tuberculosis Diagnostic Market Size (2018-2029)
8.2 China Tuberculosis Diagnostic Market Size by Type
8.2.1 China Tuberculosis Diagnostic Market Size by Type (2018-2023)
8.2.2 China Tuberculosis Diagnostic Market Size by Type (2024-2029)
8.2.3 China Tuberculosis Diagnostic Market Share by Type (2018-2029)
8.3 China Tuberculosis Diagnostic Market Size by Application
8.3.1 China Tuberculosis Diagnostic Market Size by Application (2018-2023)
8.3.2 China Tuberculosis Diagnostic Market Size by Application (2024-2029)
8.3.3 China Tuberculosis Diagnostic Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tuberculosis Diagnostic Market Size (2018-2029)
9.2 Asia Tuberculosis Diagnostic Market Size by Type
9.2.1 Asia Tuberculosis Diagnostic Market Size by Type (2018-2023)
9.2.2 Asia Tuberculosis Diagnostic Market Size by Type (2024-2029)
9.2.3 Asia Tuberculosis Diagnostic Market Share by Type (2018-2029)
9.3 Asia Tuberculosis Diagnostic Market Size by Application
9.3.1 Asia Tuberculosis Diagnostic Market Size by Application (2018-2023)
9.3.2 Asia Tuberculosis Diagnostic Market Size by Application (2024-2029)
9.3.3 Asia Tuberculosis Diagnostic Market Share by Application (2018-2029)
9.4 Asia Tuberculosis Diagnostic Market Size by Region
9.4.1 Asia Tuberculosis Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Tuberculosis Diagnostic Market Size by Region (2018-2023)
9.4.3 Asia Tuberculosis Diagnostic Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction
11.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Hologic Corporation
11.2.1 Hologic Corporation Company Details
11.2.2 Hologic Corporation Business Overview
11.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction
11.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.2.5 Hologic Corporation Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Tuberculosis Diagnostic Introduction
11.3.4 Abbott Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.3.5 Abbott Recent Developments
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Tuberculosis Diagnostic Introduction
11.4.4 Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.4.5 Becton Dickinson Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Tuberculosis Diagnostic Introduction
11.5.4 Roche Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.5.5 Roche Recent Developments
11.6 bioMerieux
11.6.1 bioMerieux Company Details
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Tuberculosis Diagnostic Introduction
11.6.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.6.5 bioMerieux Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Diagnostic Introduction
11.7.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.7.5 Sanofi Recent Developments
11.8 Cepheid
11.8.1 Cepheid Company Details
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Tuberculosis Diagnostic Introduction
11.8.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.8.5 Cepheid Recent Developments
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Details
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis Diagnostic Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.9.5 Hain Lifescience Recent Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostic Introduction
11.10.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2018-2023)
11.10.5 QIAGEN Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Radiographic Method
Table 3. Key Players of Diagnostic Laboratory Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Phage Assay
Table 6. Key Players of Detection of Latent Infection
Table 7. Key Players of Cytokine Detection Assay
Table 8. Key Players of Detection of Drug Resistance
Table 9. Global Tuberculosis Diagnostic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Tuberculosis Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Tuberculosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Tuberculosis Diagnostic Market Share by Region (2018-2023)
Table 13. Global Tuberculosis Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Tuberculosis Diagnostic Market Share by Region (2024-2029)
Table 15. Tuberculosis Diagnostic Market Trends
Table 16. Tuberculosis Diagnostic Market Drivers
Table 17. Tuberculosis Diagnostic Market Challenges
Table 18. Tuberculosis Diagnostic Market Restraints
Table 19. Global Tuberculosis Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Tuberculosis Diagnostic Revenue Share by Players (2018-2023)
Table 21. Global Top Tuberculosis Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2022)
Table 22. Global Tuberculosis Diagnostic Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Tuberculosis Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Tuberculosis Diagnostic, Headquarters and Area Served
Table 25. Global Key Players of Tuberculosis Diagnostic, Product and Application
Table 26. Global Key Players of Tuberculosis Diagnostic, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Tuberculosis Diagnostic Revenue Market Share by Type (2018-2023)
Table 30. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Tuberculosis Diagnostic Revenue Market Share by Type (2024-2029)
Table 32. Global Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Tuberculosis Diagnostic Revenue Share by Application (2018-2023)
Table 34. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Tuberculosis Diagnostic Revenue Share by Application (2024-2029)
Table 36. North America Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Tuberculosis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Tuberculosis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Tuberculosis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Tuberculosis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Tuberculosis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Tuberculosis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Tuberculosis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Tuberculosis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Tuberculosis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Tuberculosis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Tuberculosis Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Tuberculosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Tuberculosis Diagnostic Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Tuberculosis Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Tuberculosis Diagnostic Product
Table 71. Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. Hologic Corporation Company Details
Table 74. Hologic Corporation Business Overview
Table 75. Hologic Corporation Tuberculosis Diagnostic Product
Table 76. Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 77. Hologic Corporation Recent Developments
Table 78. Abbott Company Details
Table 79. Abbott Business Overview
Table 80. Abbott Tuberculosis Diagnostic Product
Table 81. Abbott Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 82. Abbott Recent Developments
Table 83. Becton Dickinson Company Details
Table 84. Becton Dickinson Business Overview
Table 85. Becton Dickinson Tuberculosis Diagnostic Product
Table 86. Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 87. Becton Dickinson Recent Developments
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Tuberculosis Diagnostic Product
Table 91. Roche Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 92. Roche Recent Developments
Table 93. bioMerieux Company Details
Table 94. bioMerieux Business Overview
Table 95. bioMerieux Tuberculosis Diagnostic Product
Table 96. bioMerieux Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 97. bioMerieux Recent Developments
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Tuberculosis Diagnostic Product
Table 101. Sanofi Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 102. Sanofi Recent Developments
Table 103. Cepheid Company Details
Table 104. Cepheid Business Overview
Table 105. Cepheid Tuberculosis Diagnostic Product
Table 106. Cepheid Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 107. Cepheid Recent Developments
Table 108. Hain Lifescience Company Details
Table 109. Hain Lifescience Business Overview
Table 110. Hain Lifescience Tuberculosis Diagnostic Product
Table 111. Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 112. Hain Lifescience Recent Developments
Table 113. QIAGEN Company Details
Table 114. QIAGEN Business Overview
Table 115. QIAGEN Tuberculosis Diagnostic Product
Table 116. QIAGEN Revenue in Tuberculosis Diagnostic Business (2018-2023) & (US$ Million)
Table 117. QIAGEN Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Tuberculosis Diagnostic Market Share by Type: 2022 VS 2029
Figure 3. Radiographic Method Features
Figure 4. Diagnostic Laboratory Methods Features
Figure 5. Nucleic Acid Testing Features
Figure 6. Phage Assay Features
Figure 7. Detection of Latent Infection Features
Figure 8. Cytokine Detection Assay Features
Figure 9. Detection of Drug Resistance Features
Figure 10. Global Tuberculosis Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Tuberculosis Diagnostic Market Share by Application: 2022 VS 2029
Figure 12. Infants Case Studies
Figure 13. Adults Case Studies
Figure 14. Tuberculosis Diagnostic Report Years Considered
Figure 15. Global Tuberculosis Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Tuberculosis Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Tuberculosis Diagnostic Market Share by Region: 2022 VS 2029
Figure 18. Global Tuberculosis Diagnostic Market Share by Players in 2022
Figure 19. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2022
Figure 21. North America Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Tuberculosis Diagnostic Market Share by Type (2018-2029)
Figure 23. North America Tuberculosis Diagnostic Market Share by Application (2018-2029)
Figure 24. North America Tuberculosis Diagnostic Market Share by Country (2018-2029)
Figure 25. United States Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Tuberculosis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Tuberculosis Diagnostic Market Share by Type (2018-2029)
Figure 29. Europe Tuberculosis Diagnostic Market Share by Application (2018-2029)
Figure 30. Europe Tuberculosis Diagnostic Market Share by Country (2018-2029)
Figure 31. Germany Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Tuberculosis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Tuberculosis Diagnostic Market Share by Type (2018-2029)
Figure 39. China Tuberculosis Diagnostic Market Share by Application (2018-2029)
Figure 40. Asia Tuberculosis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Tuberculosis Diagnostic Market Share by Type (2018-2029)
Figure 42. Asia Tuberculosis Diagnostic Market Share by Application (2018-2029)
Figure 43. Asia Tuberculosis Diagnostic Market Share by Region (2018-2029)
Figure 44. Japan Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Tuberculosis Diagnostic Market Share by Country (2018-2029)
Figure 54. Brazil Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Tuberculosis Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 61. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 62. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 63. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 64. Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 65. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 66. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 67. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 68. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 69. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Influenza Diagnostics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
  • Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
  • Global POC Diagnostics Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period. The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
  • Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period. The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
  • Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
  • Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
  • Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period. Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
  • Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Point-of-Care Diagnostics market: According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
    Published: 27-Nov-2023        Price: US 3280 Onwards        Pages: 105
    They have been used as an alternative method of diagnosing viral diseases. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs